Showing results (141-150 of 824) with videos related to
Sort By:
Pageof 83
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Therapeutic advances in relapsed or refractory multiple myelomaKenneth C AndersonSeminars in Hematology|December 14, 2005
Lenalidomide and thalidomide: mechanisms of action--similarities and differencesKenneth C AndersonExperimental Hematology|March 24, 2007
Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactionsKenneth C AndersonCancer Treatment and Research|October 4, 2016
Vision Statement for Multiple Myeloma: Future DirectionsKenneth C AndersonCancer Research|December 18, 2003
Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myelomaTeru Hideshima, Dharminder Chauhan, Toshiaki Hayashi, et al.British Journal of Haematology|April 17, 2004
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myelomaNoopur Raje, Teru Hideshima, Faith E Davies, et al.Blood|November 20, 2008
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signalingMarc S Raab, Iris Breitkreutz, Giovanni Tonon, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Novel therapies in the treatment of multiple myelomaJacob P Laubach, Constantine S Mitsiades, Anuj Mahindra, et al.Oncogene|December 4, 2003
Biologic sequelae of c-Jun NH(2)-terminal kinase (JNK) activation in multiple myeloma cell linesTeru Hideshima, Toshiaki Hayashi, Dharminder Chauhan, et al.Pageof 83